MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced that it has joined the Alliance for mRNA Medicines (AMM), as a founding member.

Legal overreaction to Supreme Court ban on race fueling loss of diversity at medical schools

Medical schools are being told by their lawyers to stop using strategies to diversify classes that are still legally permitted, despite a Supreme Court ruling

January 23, 2025

Opinion | Is It Time for Hospitals to Implement Weapons Screening?

Singh is a former emergency medicine physician, a physician coach, and a healthcare provider well-being consultant. Last month, a father reportedly shot and killed his

April 24, 2024

Pfizer ups 2024 guidance by $1B after multiple rounds of cost cuts

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.